Aquestive Therapeutics, Inc. (AQST)
6.32
+0.09
(+1.44%)
USD |
NASDAQ |
Dec 11, 16:00
6.32
0.00 (0.00%)
After-Hours: 16:33
Aquestive Therapeutics EPS Diluted (Quarterly): -0.1397 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 1.947 |
| Eli Lilly & Co. | 6.211 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| TransCode Therapeutics, Inc. | -5.825 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.45M |
| Revenue (Quarterly) | 12.81M |
| Total Expenses (Quarterly) | 28.25M |
| Enterprise Value | 759.88M |
| Gross Profit Margin (Quarterly) | 64.82% |
| Profit Margin (Quarterly) | -120.6% |
| Earnings Yield | -11.13% |
| Normalized Earnings Yield | -11.13 |